RACHELLE HANNON: Open Payments
NPI 1245989797 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 11 companies in 2025. Trend: 2023 $987 · 2024 $414 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $59 |
| Lilly USA, LLC | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MOUNJARO, VRAYLAR, CAPLYTA, GVOKE HYPOPEN, Auvelity, Cologuard Collection Kit, GARDASIL 9, REXULTI.
Industry payments across IN — which companies pay providers there.
